Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A microarray analysis of urinary microRNAs in renal diseases.

Konta T, Ichikawa K, Suzuki K, Kudo K, Satoh H, Kamei K, Nishidate E, Kubota I.

Clin Exp Nephrol. 2014 Oct;18(5):711-7. doi: 10.1007/s10157-013-0906-5. Epub 2013 Nov 6.

PMID:
24198052
2.

Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.

Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.

Eur J Clin Invest. 2015 Apr;45(4):394-404. doi: 10.1111/eci.12420.

3.

Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.

Wang G, Kwan BC, Lai FM, Chow KM, Kam-Tao Li P, Szeto CC.

Dis Markers. 2010;28(2):79-86. doi: 10.3233/DMA-2010-0687.

4.

Renal microRNA- and RNA-profiles in progressive chronic kidney disease.

Rudnicki M, Perco P, D Haene B, Leierer J, Heinzel A, Mühlberger I, Schweibert N, Sunzenauer J, Regele H, Kronbichler A, Mestdagh P, Vandesompele J, Mayer B, Mayer G.

Eur J Clin Invest. 2016 Mar;46(3):213-26. doi: 10.1111/eci.12585. Epub 2016 Jan 21.

PMID:
26707063
5.

Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.

Tencer J, Torffvit O, Björnsson S, Thysell H, Grubb A, Rippe B.

Clin Nephrol. 1997 Oct;48(4):212-9.

PMID:
9352154
6.

MicroRNAs in IgA nephropathy.

Szeto CC, Li PK.

Nat Rev Nephrol. 2014 May;10(5):249-56. doi: 10.1038/nrneph.2014.50. Epub 2014 Apr 8. Review.

PMID:
24709842
7.

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.

Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM.

Sci Rep. 2016 Mar 22;6:23498. doi: 10.1038/srep23498.

8.

MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus.

Takahashi P, Xavier DJ, Evangelista AF, Manoel-Caetano FS, Macedo C, Collares CV, Foss-Freitas MC, Foss MC, Rassi DM, Donadi EA, Passos GA, Sakamoto-Hojo ET.

Gene. 2014 Apr 15;539(2):213-23. doi: 10.1016/j.gene.2014.01.075. Epub 2014 Feb 11.

PMID:
24530307
9.

Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.

Taira K, Hewitson TD, Kincaid-Smith P.

Clin Nephrol. 1992 Jan;37(1):8-13.

PMID:
1541068
10.

Glomerulonephritis-Induced Changes in Urinary and Kidney MicroRNA Profiles in Rats.

Pavkovic M, Riefke B, Frisk AL, Gröticke I, Ellinger-Ziegelbauer H.

Toxicol Sci. 2015 Jun;145(2):348-59. doi: 10.1093/toxsci/kfv053. Epub 2015 Mar 9.

PMID:
25758243
11.

Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.

Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.

Am J Kidney Dis. 1997 Sep;30(3):404-12.

PMID:
9292570
12.

Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.

Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R.

PLoS One. 2016 Mar 1;11(3):e0150154. doi: 10.1371/journal.pone.0150154. eCollection 2016.

13.

Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy.

Tan K, Chen J, Li W, Chen Y, Sui W, Zhang Y, Dai Y.

Genome. 2013 Mar;56(3):161-9. doi: 10.1139/gen-2012-0159. Epub 2013 Mar 11.

PMID:
23659700
14.

Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy.

Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC.

Dis Markers. 2011;30(4):171-9. doi: 10.3233/DMA-2011-0766.

15.

Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.

Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, Yabe I, Utsumi J, Sasaki H.

Mol Brain. 2015 Oct 24;8(1):67. doi: 10.1186/s13041-015-0161-7.

16.

Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury.

Pavkovic M, Riefke B, Ellinger-Ziegelbauer H.

Toxicology. 2014 Oct 3;324:147-57. doi: 10.1016/j.tox.2014.05.005. Epub 2014 May 28.

PMID:
24880025
17.

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.

Wang N, Bu R, Duan Z, Zhang X, Chen P, Li Z, Wu J, Cai G, Chen X.

PeerJ. 2015 Jun 2;3:e990. doi: 10.7717/peerj.990. eCollection 2015.

18.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

19.

Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.

Szeto CC, Ching-Ha KB, Ka-Bik L, Mac-Moune LF, Cheung-Lung CP, Gang W, Kai-Ming C, Kam-Tao LP.

Dis Markers. 2012;33(3):137-44.

20.

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.

Erbes T, Hirschfeld M, Rücker G, Jaeger M, Boas J, Iborra S, Mayer S, Gitsch G, Stickeler E.

BMC Cancer. 2015 Mar 28;15:193. doi: 10.1186/s12885-015-1190-4.

Supplemental Content

Support Center